Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Kirk

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
American Family Physician|July 7, 1999
Angiotensin-II receptor antagonists: their place in therapyJ K Kirk
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
The control of imports under the Federal Food, Drug, and Cosmetic ActJ K KIRK
American Family Physician|April 1, 1995
Significant drug-nutrient interactionsJ K Kirk
American Family Physician|November 1, 1996
Alendronate: a bisphosphonate for treatment of osteoporosisJ K Kirk, J G Spangler
Archives of Family Medicine|March 1, 1995
Safe discontinuation of antihypertensive therapyJ K Kirk, S H Johnson
The Annals of Pharmacotherapy|September 1, 1995
Approaches to the treatment of hyperlipidemia in the solid organ transplant recipientJ K Kirk, R E Dupuis
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|July 9, 1998
Important features of blood glucose metersJ K Kirk, C C Rheney
The Annals of Pharmacotherapy|August 5, 2000
Performance of three blood glucose metersC C Rheney, J K Kirk
Hospital Pharmacy|November 1, 1991
Interviewing and counseling patients about immunizationsJ K Kirk, J D Grabenstein
The Journal of Family Practice|February 1, 1994
Uses and safety of acyclovir in pregnancyJ G Spangler, J K Kirk, M P Knudson
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
American Family Physician|July 7, 1999
Angiotensin-II receptor antagonists: their place in therapyJ K Kirk
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
The control of imports under the Federal Food, Drug, and Cosmetic ActJ K KIRK
American Family Physician|April 1, 1995
Significant drug-nutrient interactionsJ K Kirk
American Family Physician|November 1, 1996
Alendronate: a bisphosphonate for treatment of osteoporosisJ K Kirk, J G Spangler
Archives of Family Medicine|March 1, 1995
Safe discontinuation of antihypertensive therapyJ K Kirk, S H Johnson
The Annals of Pharmacotherapy|September 1, 1995
Approaches to the treatment of hyperlipidemia in the solid organ transplant recipientJ K Kirk, R E Dupuis
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|July 9, 1998
Important features of blood glucose metersJ K Kirk, C C Rheney
The Annals of Pharmacotherapy|August 5, 2000
Performance of three blood glucose metersC C Rheney, J K Kirk
Hospital Pharmacy|November 1, 1991
Interviewing and counseling patients about immunizationsJ K Kirk, J D Grabenstein
The Journal of Family Practice|February 1, 1994
Uses and safety of acyclovir in pregnancyJ G Spangler, J K Kirk, M P Knudson
Pageof 2